Co-transcriptional R-loops are the main cause of estrogen-induced DNA damage

eLife

Volumn 5, Issue AUGUST, 2016, Pages

  Stork, Caroline Townsend ^a   Bocek, Michael ^a   Crossley, Madzia P ^a   Sollier, Julie ^a   Sanz, Lionel A ^b   Chédin, Frédéric ^b   Swigut, Tomek ^a   Cimprich, Karlene A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; DNA; MESSENGER RNA; MUTAGENIC AGENT;

ARTICLE; BREAST CANCER; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; EPIFLUORESCENCE MICROSCOPY; EXCISION REPAIR; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NEXT GENERATION SEQUENCING; PHOSPHORYLATION; PLASMID; TRANSCRIPTION INITIATION; DOUBLE STRANDED DNA BREAK; GENETIC TRANSCRIPTION; MCF-7 CELL LINE; METABOLISM;

DNA; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; ESTROGENS; HUMANS; MCF-7 CELLS; MUTAGENS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84988470898     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.17548     Document Type: Article

References (58)

1. Alzu A, Bermejo R, Begnis M, Lucca C, Piccini D, Carotenuto W, Saponaro M, Brambati A, Cocito A, Foiani M, Liberi G. Senataxin associates with replication forks to protect fork integrity across RNA-polymerase-II-transcribed genes. Cell. 2012;151:835–846. doi: 10.1016/j.cell.2012.09.041
2. Arnold A, Papanikolaou A. Cyclin D1 in breast cancer pathogenesis. Journal of Clinical Oncology. 2005;23:4215–4224. doi: 10.1200/JCO.2005.05.064.
3. Barlow JH, Faryabi RB, Callén E, Wong N, Malhowski A, Chen HT, Gutierrez-Cruz G, Sun HW, McKinnon P, Wright G, Casellas R, Robbiani DF, Staudt L, Fernandez-Capetillo O, Nussenzweig A. Identification of early replicating fragile sites that contribute to genome instability. Cell. 2013;152:620–632. doi: 10.1016/j.cell.2013.01.006.
4. Bièche I, Parfait B, Laurendeau I, Girault I, Vidaud M, Lidereau R. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. Oncogene. 2001;20:8109–8115. doi: 10.1038/sj.onc.1204917.
5. Boguslawski SJ, Smith DE, Michalak MA, Mickelson KE, Yehle CO, Patterson WL, Carrico RJ. Characterization of monoclonal antibody to DNA.RNA and its application to immunodetection of hybrids. Journal of Immunological Methods. 1986;89:123–130. doi: 10.1016/0022-1759(86)90040-2.
6. Caldon CE. Estrogen signaling and the DNA damage response in hormone dependent breast cancers. Frontiers in Oncology. 2014;4:e17548 doi: 10.3389/fonc.2014.00106.
7. Chambers VS, Marsico G, Boutell JM, Di Antonio M, Smith GP, Balasubramanian S. High-throughput sequencing of DNA G-quadruplex structures in the human genome. Nature Biotechnology. 2015;33:877–881. doi: 10.1038/nbt.3295.
8. Cheung E, Kraus WL. Genomic analyses of hormone signaling and gene regulation. Annual Review of Physiology. 2010;72:191–218. doi: 10.1146/annurev-physiol-021909-135840.
9. Clemons M, Goss P. Estrogen and the risk of breast cancer. New England Journal of Medicine. 2001;344:276–285. doi: 10.1056/NEJM200101253440407.
10. Colditz GA. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. Journal of the National Cancer Institute. 1998;90:814–823. doi: 10.1093/jnci/90.11.814.
11. Duquette ML, Handa P, Vincent JA, Taylor AF, Maizels N. Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. Genes & Development. 2004;18:1618–1629. doi: 10.1101/gad.1200804.
12. El Hage A, French SL, Beyer AL, Tollervey D. Loss of Topoisomerase I leads to R-loop-mediated transcriptional blocks during ribosomal RNA synthesis. Genes & Development. 2010;24:1546–1558. doi: 10.1101/gad.573310.
13. Gan W, Guan Z, Liu J, Gui T, Shen K, Manley JL, Li X, Liu Z, Gui J, Shen T, Manley K. R-loop-mediated genomic instability is caused by impairment of replication fork progression. Genes & Development. 2011;25:2041–2056. doi: 10.1101/gad.17010011.
14. García-Rubio ML, Pérez-Calero C, Barroso SI, Tumini E, Herrera-Moyano E, Rosado IV, Aguilera A. The Fanconi Anemia Pathway Protects Genome Integrity from R-loops. PLoS Genetics. 2015;11:e17548 doi: 10.1371/journal.pgen.1005674.
15. Ginno PA, Lim YW, Lott PL, Korf I, Chédin F. GC skew at the 5' and 3' ends of human genes links R-loop formation to epigenetic regulation and transcription termination. Genome Research. 2013;23:1590–1600. doi: 10.1101/gr.158436.113.
16. Ginno PA, Lott PL, Christensen HC, Korf I, Chédin F. R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters. Molecular Cell. 2012;45:814–825. doi: 10.1016/j.molcel.2012.01.017.
17. Gong P, Madak-Erdogan Z, Li J, Cheng J, Greenlief CM, Helferich W, Katzenellenbogen JA, Katzenellenbogen BS. Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens. Nuclear Receptor Signaling. 2014;12:e17548 doi: 10.1621/nrs.12001.
18. Gyori BM, Venkatachalam G, Thiagarajan PS, Hsu D, Clement MV. OpenComet: an automated tool for comet assay image analysis. Redox Biology. 2014;2:457–465. doi: 10.1016/j.redox.2013.12.020.
19. Haffner MC, Aryee MJ, Toubaji A, Esopi DM, Albadine R, Gurel B, Isaacs WB, Bova GS, Liu W, Xu J, Meeker AK, Netto G, De Marzo AM, Nelson WG, Yegnasubramanian S. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nature Genetics. 2010;42:668–675. doi: 10.1038/ng.613.
20. Hah N, Danko CG, Core L, Waterfall JJ, Siepel A, Lis JT, Kraus WL. A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell. 2011;145:622–634. doi: 10.1016/j.cell.2011.03.042.
21. Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science. 2008;319:1352–1355. doi: 10.1126/science.1140735.
22. Hamperl S, Cimprich KA. The contribution of co-transcriptional RNA:DNA hybrid structures to DNA damage and genome instability. DNA Repair. 2014;19:84–94. doi: 10.1016/j.dnarep.2014.03.023.
23. Helmrich A, Ballarino M, Tora L. Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Molecular Cell. 2011;44:966–977. doi: 10.1016/j.molcel.2011.10.013.
24. Hilakivi-Clarke L, Cabanes A, Olivo S, Kerr L, Bouker KB, Clarke R. Do estrogens always increase breast cancer risk? Journal of Steroid Biochemistry and Molecular Biology. 2002;80:163–174. doi: 10.1016/S0960-0760(01)00184-4.
25. Holland DG, Burleigh A, Git A, Goldgraben MA, Perez-Mancera PA, Chin SF, Hurtado A, Bruna A, Ali HR, Greenwood W, Dunning MJ, Samarajiwa S, Menon S, Rueda OM, Lynch AG, McKinney S, Ellis IO, Eaves CJ, Carroll JS, Curtis C et al ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Molecular Medicine. 2011;3:167–180. doi: 10.1002/emmm.201100122.
26. Honkela A, Peltonen J, Topa H, Charapitsa I, Matarese F, Grote K, Stunnenberg HG, Reid G, Lawrence ND, Rattray M. Genome-wide modeling of transcription kinetics reveals patterns of RNA production delays. PNAS. 2015;112:13115–13120. doi: 10.1073/pnas.1420404112.
27. Houlard M, Artus J, Léguillier T, Vandormael-Pournin S, Cohen-Tannoudji M. DNA-RNA hybrids contribute to the replication dependent genomic instability induced by Omcg1 deficiency. Cell Cycle. 2011;10:108–117. doi: 10.4161/cc.10.1.14379.
28. Huertas P, Aguilera A. Cotranscriptionally formed DNA:RNA hybrids mediate transcription elongation impairment and transcription-associated recombination. Molecular Cell. 2003;12:711–721. doi: 10.1016/j.molcel.2003.08.010.
29. Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science. 2006;312:1798–1802. doi: 10.1126/science.1127196.
30. Kasparek TR, Humphrey TC. DNA double-strand break repair pathways, chromosomal rearrangements and cancer. Seminars in Cell & Developmental Biology. 2011;22:886–897. doi: 10.1016/j.semcdb.2011.10.007.
31. Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. Recurrent gene fusions in prostate cancer. Nature Reviews Cancer. 2008;8:497–511. doi: 10.1038/nrc2402.
32. Lavigne JA, Goodman JE, Fonong T, Odwin S, He P, Roberts DW, Yager JD. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Cancer Research. 2001;61:7488–7494.
33. Li JJ, Weroha SJ, Lingle WL, Papa D, Salisbury JL, Li SA. Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. PNAS. 2004;101:18123–18128. doi: 10.1073/pnas.0408273101.
34. Li X, Manley JL. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell. 2005;122:365–378. doi: 10.1016/j.cell.2005.06.008.
35. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocrine Reviews. 2000;21:40–54. doi: 10.1210/edrv.21.1.0386.
36. Lim YW, Sanz LA, Xu X, Hartono SR, Chédin F. Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi–Goutières syndrome. eLife. 2015;4:e17548 doi: 10.7554/eLife.08007.
37. Lin C, Yang L, Tanasa B, Hutt K, Ju BG, Ohgi K, Zhang J, Rose DW, Fu XD, Glass CK, Rosenfeld MG. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell. 2009;139:1069–1083. doi: 10.1016/j.cell.2009.11.030.
38. Marino M, Galluzzo P, Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Current Genomics. 2006;7:497–508. doi: 10.2174/138920206779315737.
39. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nature Biotechnology. 2010;28:495–501. doi: 10.1038/nbt.1630.
40. Mirzoeva OK, Petrini JH. DNA replication-dependent nuclear dynamics of the Mre11 complex. Molecular Cancer Research. 2003;1:207–218.
41. Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016;534:47–54. doi: 10.1038/nature17676.
42. Osborne C, Wilson P, Tripathy D. Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. The Oncologist. 2004;9:361–377. doi: 10.1634/theoncologist.9-4-361.
43. Paulsen RD, Soni DV, Wollman R, Hahn AT, Yee MC, Guan A, Hesley JA, Miller SC, Cromwell EF, Solow-Cordero DE, Meyer T, Cimprich KA. A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. Molecular Cell. 2009;35:228–239. doi: 10.1016/j.molcel.2009.06.021.
44. Periyasamy M, Patel H, Lai CF, Nguyen VT, Nevedomskaya E, Harrod A, Russell R, Remenyi J, Ochocka AM, Thomas RS, Fuller-Pace F, Győrffy B, Caldas C, Navaratnam N, Carroll JS, Zwart W, Coombes RC, Magnani L, Buluwela L, Ali S. APOBEC3B-Mediated cytidine deamination is required for estrogen receptor action in breast cancer. Cell Reports. 2015;13:108–121. doi: 10.1016/j.celrep.2015.08.066.
45. Santos-Pereira JM, Aguilera A. R loops: new modulators of genome dynamics and function. Nature Reviews Genetics. 2015;16:583–597. doi: 10.1038/nrg3961.
46. Santos-Pereira JM, Herrero AB, García-Rubio ML, Marín A, Moreno S, Aguilera A. The Npl3 hnRNP prevents R-loop-mediated transcription-replication conflicts and genome instability. Genes & Development. 2013;27:2445–2458. doi: 10.1101/gad.229880.113.
47. Shah KN, Faridi JS. Estrogen, tamoxifen, and Akt modulate expression of putative housekeeping genes in breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology. 2011;125:219–225. doi: 10.1016/j.jsbmb.2011.03.005.
48. Sircoulomb F, Nicolas N, Ferrari A, Finetti P, Bekhouche I, Rousselet E, Lonigro A, Adélaïde J, Baudelet E, Esteyriès S, Wicinski J, Audebert S, Charafe-Jauffret E, Jacquemier J, Lopez M, Borg JP, Sotiriou C, Popovici C, Bertucci F, Birnbaum D et al. ZNF703 gene amplification at 8p12 specifies luminal B breast cancer. EMBO Molecular Medicine. 2011;3:153–166. doi: 10.1002/emmm.201100121.
49. Skourti-Stathaki K, Kamieniarz-Gdula K, Proudfoot NJ. R-loops induce repressive chromatin marks over mammalian gene terminators. Nature. 2014;516:436–439. doi: 10.1038/nature13787.
50. Skourti-Stathaki K, Proudfoot NJ, Gromak N. Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Molecular Cell. 2011;42:794–805. doi: 10.1016/j.molcel.2011.04.026.
51. Sollier J, Cimprich KA. Breaking bad: R-loops and genome integrity. Trends in Cell Biology. 2015;25:514–522. doi: 10.1016/j.tcb.2015.05.003.
52. Sollier J, Stork CT, García-Rubio ML, Paulsen RD, Aguilera A, Cimprich KA. Transcription-coupled nucleotide excision repair factors promote R-loop-induced genome instability. Molecular Cell. 2014;56:777–785. doi: 10.1016/j.molcel.2014.10.020.
53. Tuduri S, Crabbé L, Conti C, Tourrière H, Holtgreve-Grez H, Jauch A, Pantesco V, De Vos J, Thomas A, Theillet C, Pommier Y, Tazi J, Coquelle A, Pasero P. Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription. Nature Cell Biology. 2009;11:1315–1324. doi: 10.1038/ncb1984.
54. Williamson LM, Lees-Miller SP. Estrogen receptor α-mediated transcription induces cell cycle-dependent DNA double-strand breaks. Carcinogenesis. 2011;32:279–285. doi: 10.1093/carcin/bgq255.
55. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. New England Journal of Medicine. 2006;354:270–282. doi: 10.1056/NEJMra050776.
56. Yager JD. Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review. Steroids. 2015;99:56–60. doi: 10.1016/j.steroids.2014.08.006.
57. Yang L, Luquette LJ, Gehlenborg N, Xi R, Haseley PS, Hsieh CH, Zhang C, Ren X, Protopopov A, Chin L, Kucherlapati R, Lee C, Park PJ. Diverse mechanisms of somatic structural variations in human cancer genomes. Cell. 2013;153:919–929. doi: 10.1016/j.cell.2013.04.010.
58. Yu K, Chedin F, Hsieh C-L, Wilson TE, Lieber MR. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nature Immunology. 2003;4:442–451. doi: 10.1038/ni919.